154 related articles for article (PubMed ID: 821385)
1. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.
Pardon P; Marly J
Ann Immunol (Paris); 1976; 127(1):57-70. PubMed ID: 821385
[TBL] [Abstract][Full Text] [Related]
2. Killed vaccine in adjuvant and protection of mice against an intraperitoneal challenge of Brucella: kinetic studies.
Pardon P; Marly J
Ann Rech Vet; 1976; 7(4):297-305. PubMed ID: 829301
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of a residual Brucella abortus 19 vaccine infection in mice by a virulent challenge or by injection of brucellin or of Brucella lipopolysaccharide.
Plommet M; Plommet AM
Ann Rech Vet; 1988; 19(4):245-51. PubMed ID: 3148291
[TBL] [Abstract][Full Text] [Related]
4. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
[TBL] [Abstract][Full Text] [Related]
5. Effects of killed Brucella abortus strain 45/20 vaccine on reindeer later challenge exposed with Brucella suis type 4.
Dieterich RA; Deyoe BL; Morton JK
Am J Vet Res; 1981 Jan; 42(1):131-4. PubMed ID: 6784617
[TBL] [Abstract][Full Text] [Related]
6. Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice.
Elzer PH; Rowe GE; Enright FM; Winter AJ
Am J Vet Res; 1991 Jun; 52(6):838-44. PubMed ID: 1909103
[TBL] [Abstract][Full Text] [Related]
7. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
Dénes B
Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
[TBL] [Abstract][Full Text] [Related]
8. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
9. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
Pardon P; Marly J
Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
[TBL] [Abstract][Full Text] [Related]
10. [Anti-Brucella immunity transferred by immune serum and that transferred by splenic lymphocytes cannot be added].
Plommet M; Hue I; Plommet AM
Ann Rech Vet; 1986; 17(2):169-75. PubMed ID: 3096188
[TBL] [Abstract][Full Text] [Related]
11. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
12. Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant. Level and duration of immunity in relation to dose of vaccine, recall injection and age of mice.
Bosseray N
Br J Exp Pathol; 1978 Aug; 59(4):354-65. PubMed ID: 101226
[TBL] [Abstract][Full Text] [Related]
13. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
[TBL] [Abstract][Full Text] [Related]
14. Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice.
Phillips M; Pugh GW; Deyoe BL
Am J Vet Res; 1989 Mar; 50(3):318-22. PubMed ID: 2494912
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of antibrucellosis vaccines using guinea pigs].
Le Garrec Y; Pilet C; Garrido-Calderon N
Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
[TBL] [Abstract][Full Text] [Related]
16. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
[TBL] [Abstract][Full Text] [Related]
17. Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis.
Dubray G; Bézard G
Ann Rech Vet; 1980; 11(4):367-73. PubMed ID: 6802061
[TBL] [Abstract][Full Text] [Related]
18. [Influence of the mouse genotype on the sensitivity to Brucella abortus 544].
Le Garrec Y; Garrido-Calderon N; Pilet C
Dev Biol Stand; 1976; 31():287-92. PubMed ID: 816685
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
20. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
